Åsa has many years of experience of business development and research in pharma and biotech companies. She has a solid scientific background with a Ph.D. in organic chemistry from Royal Institute of Technology, Stockholm, and hands-on experience of discovery research in the pharmaceutical industry. Åsa joined Astra (later AstraZeneca) in 1996 where she held different positions in Discovery and in the Strategic Partnering Business Development function. In 2010 she joined Spago Imaging (later Spago Nanomedical) as Director Business Development and member of the leadership team. As a result, Åsa has broad experience of corporate business development activities, strategic alliances, and global deal-making covering discovery through early clinical stage opportunities and studies, in biotech and pharma companies. Since 2015 she is the Business Development Director at Truly Translational Sweden AB.